144 related articles for article (PubMed ID: 2502419)
1. CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors.
Dianzani U; Zarcone D; Pistoia V; Grossi CE; Pileri A; Massaia M; Ferrarini M
Eur J Immunol; 1989 Jun; 19(6):1037-44. PubMed ID: 2502419
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.
Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH
Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457
[TBL] [Abstract][Full Text] [Related]
3. Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.
Bensussan A; Lagabrielle JF; Castaigne S; Boisson N; Miclea JM; Benbunan M; Degos L
Nouv Rev Fr Hematol (1978); 1989; 31(2):129-32. PubMed ID: 2528119
[TBL] [Abstract][Full Text] [Related]
4. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
[TBL] [Abstract][Full Text] [Related]
5. Morphologic and functional characterization of human peripheral blood T cells expressing the T cell receptor gamma/delta.
Ferrini S; Zarcone D; Viale M; Cerruti G; Millo R; Moretta A; Grossi CE
Eur J Immunol; 1989 Jul; 19(7):1183-8. PubMed ID: 2527156
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor activity of anti-CD3-induced activated killer cells.
Yun YS; Hargrove ME; Ting CC
Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
[TBL] [Abstract][Full Text] [Related]
10. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
11. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.
Anderson P; Nagler-Anderson C; O'Brien C; Levine H; Watkins S; Slayter HS; Blue ML; Schlossman SF
J Immunol; 1990 Jan; 144(2):574-82. PubMed ID: 2104899
[TBL] [Abstract][Full Text] [Related]
13. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
14. Functional and phenotypic differences between CD4+ and CD4- T cell receptor-gamma delta clones from peripheral blood.
Spits H; Paliard X; Vandekerckhove Y; van Vlasselaer P; de Vries JE
J Immunol; 1991 Aug; 147(4):1180-8. PubMed ID: 1831219
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
[TBL] [Abstract][Full Text] [Related]
17. Murine thymic nurse cell clone supports the growth of fetal thymocytes in the presence of interleukin 2.
Doi H; Nakagawa S; Nagata K; Hata M; Kasahara S; Sakata T; Suzuki R; Nanno M; Sugamura K; Itoh T
Eur J Immunol; 1991 Mar; 21(3):783-92. PubMed ID: 1672648
[TBL] [Abstract][Full Text] [Related]
18. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus.
Hori T; Spits H
J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic study of CD4+ and CD8+ lymphocyte subsets in relation to cytomegalovirus carrier status and its correlate with pokeweed mitogen-induced B lymphocyte differentiation.
Gratama JW; Langelaar RA; Oosterveer MA; van der Linden JA; den Ouden-Noordermeer A; Naipal AM; Visser JW; de Gast GC; Tanke HJ
Clin Exp Immunol; 1989 Aug; 77(2):245-51. PubMed ID: 2476271
[TBL] [Abstract][Full Text] [Related]
20. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
